These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 32781184)

  • 21. Utilities of Botulinum Toxins in Dermatology and Cosmetology.
    Naik PP
    Clin Cosmet Investig Dermatol; 2021; 14():1319-1330. PubMed ID: 34584436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Primary Focal Hyperhidrosis: An Algorithmic Approach.
    Liu V; Farshchian M; Potts GA
    J Drugs Dermatol; 2021 May; 20(5):523-528. PubMed ID: 33938689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-Dose OnabotulinumtoxinA using Seven-Point Pattern Intradermal Injections in Patients with Moderate-to-intolerable Primary Axillary Hyperhidrosis: A Single-Blinded, Side-by-Side Randomized Trial.
    Siri-Archawawat D; Tawanwongsri W
    J Clin Aesthet Dermatol; 2023 Jun; 16(6):37-43. PubMed ID: 37361360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review.
    Galadari H; Galadari I; Smit R; Prygova I; Redaelli A
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33671800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment approaches and outcomes associated with the use of abobotulinumtoxinA for the treatment of hyperhidrosis: A systematic review.
    Galadari H; Galadari I; Smit R; Prygova I; Redaelli A
    J Am Acad Dermatol; 2021 Nov; 85(5):1121-1129. PubMed ID: 32781184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based medicine: botulinum toxin in focal hyperhidrosis.
    Naumann M
    J Neurol; 2001 Apr; 248 Suppl 1():31-3. PubMed ID: 11357238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hyperhidrosis with botulinum toxin.
    Doft MA; Hardy KL; Ascherman JA
    Aesthet Surg J; 2012 Feb; 32(2):238-44. PubMed ID: 22328694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis.
    Nawrocki S; Cha J
    J Am Acad Dermatol; 2020 Apr; 82(4):969-979. PubMed ID: 31811879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.
    Naumann M; Dressler D; Hallett M; Jankovic J; Schiavo G; Segal KR; Truong D
    Toxicon; 2013 Jun; 67():141-52. PubMed ID: 23178324
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.